AtriCure
Logotype for AtriCure Inc

AtriCure (ATRC) investor relations material

AtriCure The Citizens Life Sciences Conference 2026 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for AtriCure Inc
The Citizens Life Sciences Conference 2026 summary10 Mar, 2026

Growth outlook and guidance for 2026

  • Organic growth expected at 12%-14% for 2026, slightly higher than 2025 guidance, driven by strong product launches and expanding adoption in core areas.

  • Pain management franchise, with recent product launches, is projected to outpace other segments, especially in the underpenetrated thoracic market.

  • New device launch for pain management in amputation procedures offers additional upside as the market matures.

  • Open heart surgery segment benefits from steady adoption of the EnCompass clamp and new AtriClip products, with growth in line with overall company guidance.

  • Standalone Afib treatment (hybrid business) remains a headwind but is expected to decline less in 2026 compared to 2025.

Product innovation and adoption trends

  • EnCompass clamp reduced procedure time from 30-45 minutes to 8-10 minutes, driving increased adoption, especially among CABG surgeons, with U.S. penetration rising to about 20% by end of 2025.

  • Pain management devices like cryoSPHERE+ and cryoSPHERE MAX have accelerated adoption by significantly reducing procedure times, with minimal barriers to adoption despite reimbursement challenges.

  • New cryoXT device targets post-amputation pain, addressing a growing market of 180,000 annual U.S. amputations, with strong initial feedback and a dedicated device design.

  • AtriClip FLEX-Mini, launched in 2024, exceeded expectations with volume-driven growth and ASP uplift, driven by demand for smaller devices.

  • AtriClip PRO-Mini enables minimally invasive procedures, but growth is limited by underlying procedure volume despite ASP improvements.

Competitive landscape and market dynamics

  • Entry of new competitors in appendage management is seen as validation of market opportunity, with innovation and clinical science as key differentiators.

  • Competition is expected to raise awareness and expand the market, with three major cardiac companies now active in appendage management.

  • In pain management, cryoanalgesia is not new, but significant capital investment and differentiated technology are barriers for new entrants.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next AtriCure earnings date

Logotype for AtriCure Inc
Q1 202628 Apr, 2026
AtriCure
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next AtriCure earnings date

Logotype for AtriCure Inc
Q1 202628 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

AtriCure Inc develops and sells medical devices for the surgical treatment of atrial fibrillation and related conditions. The company offers ablation systems, surgical instruments, and cryoablation technologies used in both open-heart and minimally invasive procedures. The company is headquartered in Mason, Ohio, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage